DrugDashboards

Robaxin

methocarbamol · METHOCARBAMOL 100 mg/mL · Injection · Intramuscular; Intravenous · Hikma Pharmaceuticals USA Inc.

NDC 00641-6103-10 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · NDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$4.51per billing unit (10 ML)HCPCS J2800 · Jul 1, 2026
  • Part D plans paid (avg)$0.1538per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$115.00
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 ML
$4.509
HCPCS J2800 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$843
146 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $11.34 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA011790
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of methocarbamol (Injection)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationMETHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Dr.Reddys Laboratories Inc.,METHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedMETHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Jvet Pharmaceuticals LlcMETHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCMETHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCMETHOCARBAMOL 100 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHOCARBAMOL 100 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Robaxin — NDC 00641-6103-10," retrieved September 3, 2026, https://drugdashboards.com/drug/00641610310.

Free to cite with attribution — see how the data is put together.